The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients

Enrolling by invitation

Phase 4 Results N/A

Summary of Purpose

The purpose of this trial is to demonstrate the efficacy and safety of dabigatran etexilate and different intensity warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 January 2016.

1 Mar 2016 3 Jan 2016 1 Jan 2018 1 Aug 2018 1 Jan 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available